1. Brawner, D.T., and Cutler, J.E., 1989, Oral Candida albicans isolates from nonhospitalized normal carriers, immunocompetent hospitalized patients, and immunocompromised patients with or without acquired immunodeficiency syndrome, J. Clin. Microbiol., 27:1335.
2. Drouhet, E., Mercier-Soucy, L., and Montplaisir, S., 1975, Sensibilité et résistance des levures pathogènes avec 5-fluoropyrimidines, Ann. Microbiol., 126B:25.
3. Drouhet, E., Dupont, B., Improvisi, L., Lesourd, M., and Provost, M.C., 1989, La cilofungine (LY121019), nouvel antifongique lipopolypeptidique agissant sur la paroi fongique. Activité in vitro sur les levures, Bull. Soc. Fr. Mycol. Med., 18:31.
4. Korting, H.C., Ollert, M., Georgii, A., and Froeschl, M., 1988, In-vitro susceptibilities and biotypes of Candida albicans isolates from the oral cavities of patients infected with human immunodeficiency virus, J. Clin. Microbiol., 26:2626.
5. Matthews, R., Burnie, J., Smith, D., Clark, I., Midgley, J., Connolly, M., and Gazzard, B., 1988, Candida and AIDS: evidence for protective antibody, Lancet, 2:263.